Selected research
Market Structure
Global Bio-based Hemostatic Powder Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Bio-based Hemostatic Powder market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Bio-based Hemostatic Powder is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Bio-based Hemostatic Powder is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Bio-based Hemostatic Powder is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Bio-based Hemostatic Powder is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Bio-based Hemostatic Powder include BD, Lanhine Medical, Yancheng Yankang Medical Equipment, Success Bio-Tech, Johnson & Johnson, Haiyuan Hairun, Beijing Aitekang Medical Technology, Baxter and Medtronic, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Bio-based Hemostatic Powder market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Bio-based Hemostatic Powder and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Bio-based Hemostatic Powder sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Bio-based Hemostatic Powder market size, projected growth trends, production technologies, key applications, and end-use industries.
Bio-based Hemostatic Powder Segment by Company
BD
Lanhine Medical
Yancheng Yankang Medical Equipment
Success Bio-Tech
Johnson & Johnson
Haiyuan Hairun
Beijing Aitekang Medical Technology
Baxter
Medtronic
MedTrade Products
Hemostasis
BioCer Entwicklungs-GmbH
Bio-based Hemostatic Powder Segment by Type
Oxidized Cellulose
Polysaccharides
Other
Bio-based Hemostatic Powder Segment by Application
Surgery
First Aid
Bio-based Hemostatic Powder Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Bio-based Hemostatic Powder market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Bio-based Hemostatic Powder and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Bio-based Hemostatic Powder.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Bio-based Hemostatic Powder market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Bio-based Hemostatic Powder manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Bio-based Hemostatic Powder in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Bio-based Hemostatic Powder in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Oxidized Cellulose
- Polysaccharides
- Other
Applications
- Surgery
- First Aid
Companies covered
- BD
- Lanhine Medical
- Yancheng Yankang Medical Equipment
- Success Bio-Tech
- Johnson & Johnson
- Haiyuan Hairun
- Beijing Aitekang Medical Technology
- Baxter
- Medtronic
- MedTrade Products
- Hemostasis
- BioCer Entwicklungs-GmbH
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Bio-based Hemostatic Powder Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Bio-based Hemostatic Powder Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Bio-based Hemostatic Powder Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Bio-based Hemostatic Powder Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Bio-based Hemostatic Powder Market Dynamics
- 2.1 Bio-based Hemostatic Powder Industry Trends
- 2.2 Bio-based Hemostatic Powder Industry Drivers
- 2.3 Bio-based Hemostatic Powder Industry Opportunities and Challenges
- 2.4 Bio-based Hemostatic Powder Industry Restraints
3 Bio-based Hemostatic Powder Market by Manufacturers
- 3.1 Global Bio-based Hemostatic Powder Revenue by Manufacturers (2021-2026)
- 3.2 Global Bio-based Hemostatic Powder Sales by Manufacturers (2021-2026)
- 3.3 Global Bio-based Hemostatic Powder Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Bio-based Hemostatic Powder Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Bio-based Hemostatic Powder Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Bio-based Hemostatic Powder Manufacturers, Product Type & Application
- 3.7 Global Bio-based Hemostatic Powder Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Bio-based Hemostatic Powder Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Bio-based Hemostatic Powder Players Market Share by Revenue in 2025
- 3.8.3 2025 Bio-based Hemostatic Powder Tier 1, Tier 2, and Tier 3
4 Bio-based Hemostatic Powder Market by Type
- 4.1 Bio-based Hemostatic Powder Type Introduction
- 4.1.1 Oxidized Cellulose
- 4.1.2 Polysaccharides
- 4.1.3 Other
- 4.2 Global Bio-based Hemostatic Powder Sales by Type
- 4.2.1 Global Bio-based Hemostatic Powder Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Bio-based Hemostatic Powder Sales by Type (2021-2032)
- 4.2.3 Global Bio-based Hemostatic Powder Sales Market Share by Type (2021-2032)
- 4.3 Global Bio-based Hemostatic Powder Revenue by Type
- 4.3.1 Global Bio-based Hemostatic Powder Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Bio-based Hemostatic Powder Revenue by Type (2021-2032)
- 4.3.3 Global Bio-based Hemostatic Powder Revenue Market Share by Type (2021-2032)
5 Bio-based Hemostatic Powder Market by Application
- 5.1 Bio-based Hemostatic Powder Application Introduction
- 5.1.1 Surgery
- 5.1.2 First Aid
- 5.2 Global Bio-based Hemostatic Powder Sales by Application
- 5.2.1 Global Bio-based Hemostatic Powder Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Bio-based Hemostatic Powder Sales by Application (2021-2032)
- 5.2.3 Global Bio-based Hemostatic Powder Sales Market Share by Application (2021-2032)
- 5.3 Global Bio-based Hemostatic Powder Revenue by Application
- 5.3.1 Global Bio-based Hemostatic Powder Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Bio-based Hemostatic Powder Revenue by Application (2021-2032)
- 5.3.3 Global Bio-based Hemostatic Powder Revenue Market Share by Application (2021-2032)
6 Global Bio-based Hemostatic Powder Sales by Region
- 6.1 Global Bio-based Hemostatic Powder Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Bio-based Hemostatic Powder Sales by Region (2021-2032)
- 6.2.1 Global Bio-based Hemostatic Powder Sales by Region (2021-2026)
- 6.2.2 Global Bio-based Hemostatic Powder Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Bio-based Hemostatic Powder Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Bio-based Hemostatic Powder Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Bio-based Hemostatic Powder Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Bio-based Hemostatic Powder Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Bio-based Hemostatic Powder Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Bio-based Hemostatic Powder Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Bio-based Hemostatic Powder Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Bio-based Hemostatic Powder Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Bio-based Hemostatic Powder Revenue by Region
- 7.1 Global Bio-based Hemostatic Powder Revenue by Region
- 7.1.1 Global Bio-based Hemostatic Powder Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Bio-based Hemostatic Powder Revenue by Region (2021-2026)
- 7.1.3 Global Bio-based Hemostatic Powder Revenue by Region (2027-2032)
- 7.1.4 Global Bio-based Hemostatic Powder Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Bio-based Hemostatic Powder Revenue (2021-2032)
- 7.2.2 North America Bio-based Hemostatic Powder Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Bio-based Hemostatic Powder Revenue (2021-2032)
- 7.3.2 Europe Bio-based Hemostatic Powder Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Bio-based Hemostatic Powder Revenue (2021-2032)
- 7.4.2 Asia-Pacific Bio-based Hemostatic Powder Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Bio-based Hemostatic Powder Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Bio-based Hemostatic Powder Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 BD
- 8.1.1 BD Company Information
- 8.1.2 BD Business Overview
- 8.1.3 BD Bio-based Hemostatic Powder Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 BD Bio-based Hemostatic Powder Product Portfolio
- 8.1.5 BD Recent Developments
- 8.2 Lanhine Medical
- 8.2.1 Lanhine Medical Company Information
- 8.2.2 Lanhine Medical Business Overview
- 8.2.3 Lanhine Medical Bio-based Hemostatic Powder Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Lanhine Medical Bio-based Hemostatic Powder Product Portfolio
- 8.2.5 Lanhine Medical Recent Developments
- 8.3 Yancheng Yankang Medical Equipment
- 8.3.1 Yancheng Yankang Medical Equipment Company Information
- 8.3.2 Yancheng Yankang Medical Equipment Business Overview
- 8.3.3 Yancheng Yankang Medical Equipment Bio-based Hemostatic Powder Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Yancheng Yankang Medical Equipment Bio-based Hemostatic Powder Product Portfolio
- 8.3.5 Yancheng Yankang Medical Equipment Recent Developments
- 8.4 Success Bio-Tech
- 8.4.1 Success Bio-Tech Company Information
- 8.4.2 Success Bio-Tech Business Overview
- 8.4.3 Success Bio-Tech Bio-based Hemostatic Powder Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 Success Bio-Tech Bio-based Hemostatic Powder Product Portfolio
- 8.4.5 Success Bio-Tech Recent Developments
- 8.5 Johnson & Johnson
- 8.5.1 Johnson & Johnson Company Information
- 8.5.2 Johnson & Johnson Business Overview
- 8.5.3 Johnson & Johnson Bio-based Hemostatic Powder Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 Johnson & Johnson Bio-based Hemostatic Powder Product Portfolio
- 8.5.5 Johnson & Johnson Recent Developments
- 8.6 Haiyuan Hairun
- 8.6.1 Haiyuan Hairun Company Information
- 8.6.2 Haiyuan Hairun Business Overview
- 8.6.3 Haiyuan Hairun Bio-based Hemostatic Powder Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 Haiyuan Hairun Bio-based Hemostatic Powder Product Portfolio
- 8.6.5 Haiyuan Hairun Recent Developments
- 8.7 Beijing Aitekang Medical Technology
- 8.7.1 Beijing Aitekang Medical Technology Company Information
- 8.7.2 Beijing Aitekang Medical Technology Business Overview
- 8.7.3 Beijing Aitekang Medical Technology Bio-based Hemostatic Powder Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 Beijing Aitekang Medical Technology Bio-based Hemostatic Powder Product Portfolio
- 8.7.5 Beijing Aitekang Medical Technology Recent Developments
- 8.8 Baxter
- 8.8.1 Baxter Company Information
- 8.8.2 Baxter Business Overview
- 8.8.3 Baxter Bio-based Hemostatic Powder Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.8.4 Baxter Bio-based Hemostatic Powder Product Portfolio
- 8.8.5 Baxter Recent Developments
- 8.9 Medtronic
- 8.9.1 Medtronic Company Information
- 8.9.2 Medtronic Business Overview
- 8.9.3 Medtronic Bio-based Hemostatic Powder Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.9.4 Medtronic Bio-based Hemostatic Powder Product Portfolio
- 8.9.5 Medtronic Recent Developments
- 8.10 MedTrade Products
- 8.10.1 MedTrade Products Company Information
- 8.10.2 MedTrade Products Business Overview
- 8.10.3 MedTrade Products Bio-based Hemostatic Powder Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.10.4 MedTrade Products Bio-based Hemostatic Powder Product Portfolio
- 8.10.5 MedTrade Products Recent Developments
- 8.11 Hemostasis
- 8.11.1 Hemostasis Company Information
- 8.11.2 Hemostasis Business Overview
- 8.11.3 Hemostasis Bio-based Hemostatic Powder Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.11.4 Hemostasis Bio-based Hemostatic Powder Product Portfolio
- 8.11.5 Hemostasis Recent Developments
- 8.12 BioCer Entwicklungs-GmbH
- 8.12.1 BioCer Entwicklungs-GmbH Company Information
- 8.12.2 BioCer Entwicklungs-GmbH Business Overview
- 8.12.3 BioCer Entwicklungs-GmbH Bio-based Hemostatic Powder Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.12.4 BioCer Entwicklungs-GmbH Bio-based Hemostatic Powder Product Portfolio
- 8.12.5 BioCer Entwicklungs-GmbH Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Bio-based Hemostatic Powder Value Chain Analysis
- 9.1.1 Bio-based Hemostatic Powder Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Bio-based Hemostatic Powder Production Mode & Process
- 9.2 Bio-based Hemostatic Powder Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Bio-based Hemostatic Powder Distributors
- 9.2.3 Bio-based Hemostatic Powder Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst